Windtree Therapeutics has signed a $520 million new financing agreement, which will be used to purchase BNB.

By: theblockbeats.news|2025/07/25 11:22:18

BlockBeats News, July 25th, Nasdaq-listed biotechnology company Windtree Therapeutics (WINT) announced that it has entered into a share purchase agreement of up to $500 million to establish an Equity Line of Credit (ELOC). Additionally, the company has also signed an additional $20 million stock purchase agreement with Build and Build Corp.

The total funding size of this round reaches up to $520 million, with 99% of the funds to be used to purchase BNB. The company plans to officially start using the funds after obtaining shareholder approval to increase the number of authorized common shares.

-- Price

Most crypto traders lose money not because of bad luck, but because they misunderstand how the market really works. From Freedom of Money to the rise and fall of Sam Bankman-Fried, they highlight a key divide in crypto: those who build the market and those who chase it. This reading guide explores essential books that reveal how narrative, regulation, capital, and psychology shape long-term success in the crypto industry.

The Risk Management Core Team has just been ousted, and Aave is now facing a $200 million default.

rsETH attack is just the tip of the iceberg, Aave is an approved insolvency

The $293 million bug wasn't in the code; so, what's the deal with the "DVN Configuration Bug," which led to the largest hack of 2026?

「Audit Passed」 these four words do not cover the location of the parameter.

a16z on Recruitment: How to Choose Between Crypto-Native and Traditional Talent?

Is it someone with encryption experience or someone with outstanding quick learning ability?

The biggest DeFi heist of 2026, hackers easily took advantage of Aave

A fake news story swindled 292 million dollars: Kelp DAO's cross-chain bridge was drained in 46 minutes.

Will Robots Replace Humans? He Says No!

Robots will not replace humans, but will rewrite the division of labor

Binance Coin's Price Skyrockets 15x to All-Time High, Saved by Three Bull Market Lifelines

Bringing Back the Long-Awaited Meme Coin Volatility

The organization has accessed the prediction market, but is stuck at the third stage

The proportion of sports categories on Kalshi is at a historical low, shifting from "entertainment trading" to "information and risk tools."

Head of crypto VC collective shrinks: a16z crypto fund management scale plummets by 40%, Multicoin cut in half

The only one experiencing counter-cyclical growth is Haun Ventures, which hit the jackpot in the stablecoin sector with BVNK being acquired by Mastercard.

Arthur Hayes New Post: It's "No Trade" Time Now

When volatility truly spirals out of control and liquidity is forcefully unleashed, the market will re-enter a tradable phase.

Claude Opus 4.7 Review: Is It Worthy of the Title of Strongest Model?

Opus 4.7 is a surgical, precision-based release with clear trade-offs.

DWF In-Depth Report: AI Outperforms Humans in Yield Farming Optimization in DeFi, But Complex Transactions Still Lag Behind 5x

Across agents, model selection and risk management have the most significant impact on transaction performance.

The financial tricks of the crypto giant Kraken

After Coinbase, several other cryptocurrency exchanges have entered the capital market. Will Wall Street still pay a premium for the same story?